Ticker
IGCCompany Name
IGC PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 7.94M | $ 610K | 7.68% |
3/31/2025 | $ 8.75M | $ 619K | 7.08% |
12/31/2024 | $ 9.08M | $ 636K | 7.01% |
9/30/2024 | $ 10.37M | $ 665K | 6.41% |
6/30/2024 | $ 10.59M | $ 641K | 6.05% |
3/31/2024 | $ 9.9M | $ 733K | 7.4% |
12/31/2023 | $ 11.26M | $ 625K | 5.55% |
9/30/2023 | $ 16.51M | $ 594K | 3.6% |
6/30/2023 | $ 15.67M | $ 555K | 3.54% |
3/31/2023 | $ 17.18M | $ 442K | 2.57% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for IGC PHARMA INC is calculated as follows: GP [ $ 118K ] / Assets [ $ 26.35M ]
(=) GPA [ 0.45% ]
Minimum
Jun 30, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 84.08% |
average | 20.16% |
median | 15.34% |
std | 19.94% |